Bisaro Paul (CIK 1237253) reported 9 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2026-06-05). Recent activity: Buy MYGN (59,701 shares), Buy MYGN (7,500 shares), Buy ZTS (2,000 shares), Buy ZTS (1,619 shares), Sell NONE (854 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-05 | MYRIAD GENETICS INC (MYGN) | Director | Buy | 59,701 | $0 |
| 2026-05-14 | MYRIAD GENETICS INC (MYGN) | Director | Buy | 7,500 | $27,638 |
| 2026-05-13 | Zoetis Inc. (ZTS) | Director | Buy | 2,000 | $151,750 |
| 2026-02-23 | Zoetis Inc. (ZTS) | Director | Buy | 1,619 | $0 |
| 2026-01-05 | Keenova Therapeutics plc (NONE) | Director | Sell | 854 | $0 |
| 2026-01-05 | Keenova Therapeutics plc (NONE) | Director | Buy | 3,014 | $0 |
| 2025-06-06 | MYRIAD GENETICS INC (MYGN) | Director | Buy | 49,796 | $0 |
| 2025-02-11 | Zoetis Inc. (ZTS) | Director | Buy | 1,225 | $0 |
| 2025-02-10 | Zoetis Inc. (ZTS) | Director | Buy | 1,236 | $0 |
Source: SEC Form 4 filings · as of 2026-06-05